CWBC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Buy now: price is in a clear uptrend (bullish moving-average stack + expanding positive MACD) and fundamentals are accelerating (2025/Q4 revenue +13% YoY, EPS +61% YoY).", "Wall Street targets imply upside from $25.21 (DA Davidson PT $29; KBW PT $26), with sentiment skewing constructive after the earnings beat and acquisition rationale.", "Expect near-term choppiness because momentum is overheated (RSI_6 ~84), but for an impatient buyer the trend + earnings momentum still supports entry today."]
["Trend: Bullish (SMA_5 > SMA_20 > SMA_200), indicating sustained upward momentum across short/medium/long-term horizons.", "Momentum: MACD histogram +0.198 and expanding, confirming bullish momentum is strengthening.", "Overbought: RSI_6 at 84.33 suggests stretched conditions; probability favors a brief pause/pullback rather than a straight-line rally.", "Levels: Pivot 24.234 as key support reference; near resistance sits around R2 25.599 (price $25.21 is already above R1 25.078, implying a near-term resistance test).", "Pattern-based outlook: Similar-pattern stats show slightly negative skew next day/week (-0.82% / -0.85%) but positive over next month (+2.49%)."]
["Strong 2025/Q4 growth: revenue +12.98% YoY, net income +62% YoY, EPS +61.11% YoY.", "Analyst upgrades/target raises following Q3 beat: DA Davidson raised PT to $29 and reiterated Buy, citing NIM expansion, ~11% avg loan growth, strong asset quality/low provisioning.", "UBFO acquisition narrative: expected earnings accretion (noted by KBW) and strengthening deposit franchise strategy.", "No bearish flow flagged: hedge funds and insiders show neutral activity (no notable recent selling pressure indicated)."]
at ~84 increases odds of near-term consolidation right after the recent run.", "Lack of near-term news catalysts: no notable news in the last week to drive immediate incremental demand.", "Analyst stance is mixed overall: alongside one Buy, KBW remains Market Perform (less conviction for immediate multiple expansion).", "Options market is illiquid today (zero volume), reducing the usefulness of sentiment confirmation from derivatives."]
["Latest quarter: 2025/Q4.", "Revenue: $36.266M, +12.98% YoY (top-line growth re-accelerating).", "Net income: $11.17M, +62.00% YoY (strong profitability leverage).", "EPS: $0.58, +61.11% YoY (earnings momentum supports the uptrend)."]
["2026-01-26: DA Davidson raised PT to $29 from $26; reiterated Buy after Q3 beat (highlighted NIM expansion, loan growth, asset quality).", "2026-01-23: Keefe Bruyette raised PT to $26 from $25; maintained Market Perform.", "2025-12-31: Keefe Bruyette raised PT to $25 from $23 post-UBFO acquisition; maintained Market Perform (deal seen accretive to 2027 EPS; tangible book dilution with ~3-year earnback).", "Wall Street pros: improving fundamentals, NIM/loan growth, strong asset quality, acquisition synergy potential.", "Wall Street cons: not a unanimous Buy; some view valuation/upside as more limited near current levels, consistent with Market Perform ratings."]
